U.S. Patent for Bioelectric Expression of Klotho, a Key Longevity and Disease-Fighting Protein Issued to Leonhardt Ventures Mission Viejo, California, United States, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Leonhardt Ventures, LLC  is pleased to announce the United States Patent and Trademark Office (USPTO) has issued U.S....

Leonhardt Ventures Announces Launch of Research Program Using Patent Pending Klotho Expressing Mesenchymal Stem Cells for Multiple Applications in Combination with Bioelectric Protein Expressions Mission Viejo, California, United States, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC, a Mission Viejo, California based company via it's innovation and startup launch accelerator...

Leonhardt Ventures Files Patent for Bioelectric Diabetes Reversal Treatment via FABp4 Regulation and Klotho Regulation Mission Viejo, California, United States, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC announced today filing of a patent application covering bioelectric controlled down regulation of...

Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing Mission Viejo, California, United States, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Leonhardt Ventures LLC, an innovation and venture creation company focused on the convergence of bioelectrics and...